Literature DB >> 32594720

[Chinese experts consensus on clinical practice of the selection and establishment of fecal microbiota transplantation delivery routes].

.   

Abstract

Fecal microbiota transplantation (FMT) has gradually shown application prospects in the treatment of intestinal and extraintestinal diseases. In order to standardized FMT operation, based on the clinical experience of the Tenth People's Hospital Affiliated to Tongji University, combined with domestic and foreign literature, Parenteral and Enteral Nutrition Branch of Chinese Medical Association, Enhanced Recovery after Surgery Branch of China International Health Care Promotion Exchange Association, China Microecological Treatment Innovation Alliance, and Microecology Committee of Shanghai Preventive Medicine Association to formulated the" Chinese experts consensus on clinical practice of the selection and establishment of fecal microbiota transplantation delivery routes". It includes four parts: the selection of delivery route, the methodology of transplantation path establishment, the clinical application, and the monitoring of adverse events.

Entities:  

Keywords:  Clinical application; Consensus; Delivery routes; Fecal microbiota transplantation

Mesh:

Year:  2020        PMID: 32594720     DOI: 10.3760/cma.j.cn.441530-20200420-00228

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  2 in total

Review 1.  Adverse events of intestinal microbiota transplantation in randomized controlled trials: a systematic review and meta-analysis.

Authors:  Chong Chen; Liyu Chen; Dayong Sun; Cailan Li; Shiheng Xi; Shihua Ding; Rongrong Luo; Yan Geng; Yang Bai
Journal:  Gut Pathog       Date:  2022-05-26       Impact factor: 5.324

2.  FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder.

Authors:  Ye Chen; Zhang Xueying; Cui Jiaqu; Chen Qiyi; Qin Huanlong; Li Ning; Du Yasong; Zhao Xiaoxin; Yang Rong; Lu Jubao; Lv Xiaoqiong; Ma Chunlian; Wang Yu; Chen Shidong; Kuang Guifang; Zhao Dongmei; Fang Shuanfeng; Zhang Xujing; Yang Binrang; Wang Yanxia; Li Ling; Yuan Song; Zhou Xiang; Zhang Beihua; Jiang Lin; Ji Hong
Journal:  BMJ Open       Date:  2022-01-31       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.